Showing 4651-4660 of 5771 results for "".
- Sanofi, Regeneron’s Kevzara Fails Late-Stage Study in COVID-19https://modernod.com/news/sanofi-regenerons-kevzara-fails-late-stage-study-in-covid-19/2477966/Sanofi and Regeneron Pharmaceuticals announced Thursday that a phase 3 trial of their rheumatoid arthritis drug Kevzara (sarilumab) 400 mg in COVID-19 patients requiring mechanical ventilation did not meet its primary and key secondary endpoints when the IL-6 receptor antibody was added to best s
- American Academy of Ophthalmology to Launch its First Open Access Journal in Early 2021https://modernod.com/news/american-academy-of-ophthalmology-to-launch-its-first-open-access-journal-in-early-2021/2477962/The American Academy of Ophthalmology announced plans to expand the Ophthalmology family of journals to include Ophthalmology Science, an online open access journal focused on publishing preclinical development, phase 1 and 2 clinical trials, laboratory-based work, ophthalmology
- SparingVision Receives European Orphan Designation for its Drug Candidate SPVN06 Dedicated to Inherited Retinal Dystrophieshttps://modernod.com/news/sparingvision-receives-european-orphan-designation-for-its-drug-candidate-spvn06-dedicated-to-inherited-retinal-dystrophies/2477959/SparingVision announced the decision of the European Commission to grant Orphan Drug Designation for SPVN06 for the treatment of inherited retinal dystrophies. The decision is based on a positive opinion from the European Medicine Agency’s (EMA) Committee for Orphan Medicinal Products (COMP).
- Oculight Launches US Subsidiary OCU L&Chttps://modernod.com/news/oculight-launches-us-subsidiary-ocu-lc/2477956/Oculight announced the launch of OCU L&C, a fully-owned U.S. subsidiary. OCU L&C will focus on the commercialization of its products in the U.S. Oculight is an ophthalmic medical device developer based in Korea founded in 2017 by Dr.
- Remdesivir, the First Coronavirus Drug, Gets a Price Taghttps://modernod.com/news/remdesivir-the-first-coronavirus-drug-gets-a-price-tag/2477953/Remdesivir, the first drug shown to be effective against the coronavirus, will be distributed under an unusual agreement with the federal government that establishes nonnegotiable prices and prioritizes American patients, health officials announced on Monday, accordin
- Samsung Bioepis Initiates Phase 3 Clinical Trial for SB15, Proposed Biosimilar to Eylea (Aflibercept)https://modernod.com/news/samsung-bioepis-initiates-phase-3-clinical-trial-for-sb15-proposed-biosimilar-to-eylea-aflibercept/2477950/Samsung Bioepis announced the initiation of phase 3 clinical trial for SB15, the company’s proposed biosimilar referencing Eylea (aflibercept). The trial is a randomized, double-masked, parallel group, multicenter study to compare the efficacy, safety, pharmacokinetics, and immunogenicity b
- Santen and Singapore’s Health-Tech Start-up, Plano, Form a Strategic Alliance to Tackle the Global Burden of Myopiahttps://modernod.com/news/santen-and-singapores-health-tech-start-up-plano-form-a-strategic-alliance-to-tackle-the-global-burden-of-myopia/2477947/Santen Pharmaceutical and Plano announced a strategic alliance to tackle the global burden of myopia. Under the alliance, Plano has secured an investment from Santen with the goal of tackling the burden of myopia using both a holistic approach and innovative technological solutions. “
- The Vision Council Raises $38,100 for Justice Initiativeshttps://modernod.com/news/the-vision-council-raises-38100-for-justice-initiatives/2477948/The Vision Council is pleased to announce that the organization’s “Open Your Eyes Frame Vendue” has raised $38,100 for the Equal Justice Initiative and My Brother’s Keeper Alliance. The week-long virtual auction featured frames with special significance, including one-of-a-kind or nev
- Envision Conference Goes Virtual This Augusthttps://modernod.com/news/envision-conference-goes-virtual-this-august/2477945/Envision has announced that it is shifting the format for Envision Conference East to a live-stream webinar occurring August 14-15, 2020. In addition to creating a safer environment in the midst of the COVID-19 crisis, the virtual format will facilitate participation in
- Epipole Raises $1.9 million, Appoints Former Optos Exec as Chairmanhttps://modernod.com/news/epipole-raises-1-9-million-appoints-former-optos-exec-as-chairman/2477943/Video retinal imaging company Epipole announced that it has secured £1.5 million ($1.9 million) in new funding to prepare for introduction into the United States ophthalmic imaging market. Epipole’s patented technology enables clinicians to scan the retina using real-time video and then e